Clinical trial
Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound
NCT01043380 is registered in ClinicalTrials.gov with Kumamoto University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound
- Lead sponsor
- Kumamoto University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- September 30, 2014
- Enrollment
- 245 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.